Creative Planning
TNDM icon

Creative Planning’s Tandem Diabetes Care TNDM Stock Holding History

Creative Planning’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-9,478
Closed -$208K – 4202
2025
Q4 		$208K Sell
9,478
-812
-8% -$14.7K ﹤0.01% 3510
2025
Q3 		$125K Buy
+10,290
New +$139K ﹤0.01% 3633
2025
Q1 		– Sell
-7,582
Closed -$273K – 3716
2024
Q4 		$273K Sell
7,582
-2,958
-28% -$100K ﹤0.01% 2738
2024
Q3 		$447K Sell
10,540
-1,395
-12% -$59.1K ﹤0.01% 2204
2024
Q2 		$481K Buy
11,935
+3,461
+41% +$144K ﹤0.01% 1973
2024
Q1 		$300K Buy
8,474
+670
+9% +$18K ﹤0.01% 2253
2023
Q4 		$231K Buy
7,804
+7,679
+6,143% +$159K ﹤0.01% 2300
2023
Q3 		$2.6K Buy
+125
New +$3.43K ﹤0.01% 2789
2023
Q2 		– Sell
-5,687
Closed -$231K – 2822
2023
Q1 		$231K Sell
5,687
-1,085
-16% -$44.9K ﹤0.01% 2010
2022
Q4 		$304K Buy
6,772
+1,290
+24% +$58.4K ﹤0.01% 1721
2022
Q3 		$262K Buy
5,482
+1,297
+31% +$71.1K ﹤0.01% 1737
2022
Q2 		$248K Buy
4,185
+772
+23% +$63.4K ﹤0.01% 1737
2022
Q1 		$397K Buy
3,413
+405
+13% +$47.3K ﹤0.01% 1457
2021
Q4 		$453K Sell
3,008
-163
-5% -$22K ﹤0.01% 1374
2021
Q3 		$379K Hold
3,171
– – ﹤0.01% 1453
2021
Q2 		$309K Buy
+3,171
New +$283K ﹤0.01% 1546
2020
Q2 		– Sell
-6,379
Closed -$410K – 2129
2020
Q1 		$410K Sell
6,379
-11,150
-64% -$781K ﹤0.01% 1047
2019
Q4 		$1.04M Sell
17,529
-105
-0.6% -$6.47K ﹤0.01% 773
2019
Q3 		$1.04M Sell
17,634
-1,383
-7% -$88.3K ﹤0.01% 739
2019
Q2 		$1.23M Buy
19,017
+735
+4% +$47.4K ﹤0.01% 685
2019
Q1 		$1.16M Sell
18,282
-5,147
-22% -$270K ﹤0.01% 672
2018
Q4 		$890K Sell
23,429
-1,700
-7% -$60K ﹤0.01% 716
2018
Q3 		$1.08M Buy
25,129
+4,129
+20% +$144K ﹤0.01% 737
2018
Q2 		$462K Sell
21,000
-5,000
-19% -$61.5K ﹤0.01% 1109
2018
Q1 		$129K Buy
26,000
+8,000
+44% +$25.8K ﹤0.01% 1705
2017
Q4 		$42K Buy
+18,000
New +$56.5K ﹤0.01% 1811
2016
Q1 		– Sell
-22
Closed -$3K – 4522
2015
Q4 		$3K Buy
22
+20
+1,000% +$1.98K ﹤0.01% 3933
2015
Q3 		$0 Buy
+2
New +$233 ﹤0.01% 4357

Other funds holding TNDM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SC
Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Creative Planning's TNDM Position: Q1 2026 in Review

Creative Planning sold out of Tandem Diabetes Care (TNDM) in Q1 2026, closing a stake of 9,478 shares — an estimated $208K sold.

Creative Planning first reported a position in TNDM in Q3 2015 and held it in 28 quarters. The position peaked at $1.23M in Q2 2019. 272 funds tracked by Wall St. Rank hold TNDM as of Q1 2026.

  • Creative Planning reported no remaining Tandem Diabetes Care position as of Q1 2026 after selling out during the quarter.
  • Creative Planning sold 9,478 Tandem Diabetes Care shares in Q1 2026, an estimated $208K.
  • Creative Planning first reported a position in Tandem Diabetes Care in Q3 2015 and held it in 28 quarters.
  • Creative Planning's Tandem Diabetes Care position peaked at $1.23M in Q2 2019.
  • 272 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2026.

Based on Creative Planning's 13F filing for Q1 2026, filed 12 May 2026.